Article thumbnail

Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence

By Jason E. Farley, Malathi Ram, William Pan, Stacie Waldman, Gail H. Cassell, Richard E. Chaisson, Karin Weyer, Joey Lancaster and Martie Van der Walt
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.
  2. (2009). Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from
  3. (2006). Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
  4. (2005). Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.
  5. (2010). Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
  6. (2009). Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis.
  7. (2006). Cost-effectiveness of treating multidrug-resistant tuberculosis.
  8. (1999). Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.
  9. (2008). Exogenous reinfection as a cause of multidrug-resistant and extensively drugresistant tuberculosis in rural South Africa.
  10. (2006). Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
  11. (2001). Harries A
  12. (2010). Health Republic of South Africa
  13. (2010). High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa,
  14. (2010). HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.
  15. (2007). HIV infection and multidrug-resistant tuberculosis: the perfect storm.
  16. (2011). Locally written SAS Macros. Division of Biomedical Statistics and Informatics,
  17. (2006). Multidrug-resistant tuberculosis management in resource-limited settings.
  18. (2007). Multidrugresistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures.
  19. (2010). Organization (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB):
  20. (2004). Outcome of HIVassociated tuberculosis in the era of highly active antiretroviral therapy.
  21. (2001). Public health. Responding to market failures in tuberculosis control.
  22. (2011). Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
  23. (2006). Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa,
  24. (2005). Speaking the same language: treatment outcome definitions for multidrugresistant tuberculosis.
  25. (2009). Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq’oba study.
  26. (2009). The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa.
  27. (2008). Treatment outcome and follow-up of multidrug-resistant tuberculosis patients,
  28. (2009). Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
  29. (2009). Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and metaanalysis.
  30. (2007). Tuberculosis, drug resistance, and HIV/AIDS: a triple threat.
  31. (2008). World Health Organization